MorphoSys AG Reports Second Quarter 2018 Financial Results news with...
DGAPNews MorphoSys AG Key words Half Year Results01.08.2018 2201 The issuer is solely responsible for the content of this announcement.PlaneggMunich Germany August 1 2018 MorphoSys AG Reports Second...
View ArticleGalapagos NV GLPG Pharmaceuticals Healthcare Deals and Alliances Profile...
SummaryGalapagos NV Galapagos is a biotechnology company that discovers and develops pharmaceutical products. The company's product pipeline encompasses investigational candidates targeted at the...
View ArticleAevi Genomic Medicine Inc GNMX Pharmaceuticals Healthcare Deals and Alliances...
SummaryAevi Genomic Medicine Inc Aevi formerly Medgenics Inc is a research and development company that discovers and develops novel therapies for pediatric onset and lifealtering diseases.The...
View ArticleRP Management LLC Pharmaceuticals Healthcare Deals and Alliances Profile...
SummaryRP Management LLC RP Management is a life sciences financing company that offers biopharmaceutical products. The company's products include thalomid myozyme lexiscan rituxan atripla lyrica...
View ArticleAevi Genomic Medicine Inc GNMX Medical Equipment Deals and Alliances Profile...
SummaryAevi Genomic Medicine Inc Aevi formerly Medgenics Inc is a research and development company that discovers and develops novel therapies for pediatric onset and lifealtering diseases.The...
View ArticleRedHill Biopharma Ltd RDHL Pharmaceuticals Healthcare Deals and Alliances...
SummaryRedHill Biopharma Ltd RedHill is a biopharmaceutical company that develops and commercializes therapeutics in the areas of gastroenterology GI and cancer. The company's commercial product...
View ArticleStrategic Appointment Expands Atlantic Healthcare Executive Team
Strategic appointment expands Atlantic Healthcare executive team U.S. President and COO appointed to lead commercialisation of alicaforsenCAMBRIDGE England PRWEB August 02 2018 Atlantic Healthcare plc...
View ArticleIL23Specific Antibody Ups Response in AntiTNFRefractory Crohn's
MedPage Today Subcutaneous risankizumab also looks promising for maintaining remission
View ArticleRedhills RHB104 are antibiotics the answer to Crohns disease
On July 30 RedHill Biopharma announced topline safety and efficacy results from the first Phase III study of RHB104 a...Read More...The post Redhill&8217;s RHB104 are antibiotics the answer to...
View ArticleIntegrin Alpha 4 CD49 Antigen Like Family Member D or VLA4 Subunit Alpha or...
Integrin Alpha 4 CD49 Antigen Like Family Member D or VLA4 Subunit Alpha or CD49d or ITGA4 Pipeline Review H2 2018SummaryIntegrin Alpha 4 CD49 Antigen Like Family Member D or VLA4 Subunit Alpha or...
View ArticleFred Hutchinson Cancer Research Center Pharmaceuticals Healthcare Deals and...
SummaryFred Hutchinson Cancer Research Center Fred Hutchinson a subsidiary of National Comprehensive Cancer Network is a nonprofit organization which conducts research on the prevention diagnose and...
View ArticleMetabolomic Technologies Inc Medical Equipment Deals and Alliances Profile...
SummaryMetabolomic Technologies Inc MTI is a biotechnology company that develops metabolomicbased diagnostic systems. The company's products comprise ColoDx PolypDx BreastDx ProstateDx CeliacDx...
View ArticleInterleukin 7 Receptor Subunit Alpha CDw127 or CD127 or IL7R Pipeline Review...
Interleukin 7 Receptor Subunit Alpha CDw127 or CD127 or IL7R Pipeline Review H2 2018SummaryInterleukin 7 Receptor Subunit Alpha CDw127 or CD127 or IL7R pipeline Target constitutes close to 6 molecules....
View ArticleCalypso Biotech SA Pharmaceuticals Healthcare Deals and Alliances Profile...
SummaryCalypso Biotech SA Calypso is a biopharmaceutical company that develops antibody therapies. The company provides pipeline products such as CALY0001 and CALY0002. Its CALY0001 therapeutic...
View ArticleDeciphera Pharmaceuticals LLC DCPH Pharmaceuticals Healthcare Deals and...
SummaryDeciphera Pharmaceuticals LLC Deciphera Pharmaceuticals is a research and development company that develops designs and commercializes kinase inhibiting drugs. The company's clinical pipeline of...
View ArticleStem cell transplants to be used in treating Crohn's disease
Queen Mary University of London A clinical trial has begun which will use stem cell transplants to grow a new immune system for people with untreatable Crohn's disease a painful and chronic intestinal...
View ArticleClinical trial to use stem cell transplants for treating Crohn's disease
A clinical trial has begun which will use stem cell transplants to grow a new immune system for people with untreatable Crohn's disease a painful and chronic intestinal disease which affects at least...
View ArticleSoligenix Inc SNGX Financial and Strategic SWOT Analysis Review Report...
Soligenix Inc SNGX Financial and Strategic SWOT Analysis Review provides you an indepth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData...
View ArticleTumor Necrosis Factor Receptor Superfamily Member 5 B Cell Surface Antigen...
Tumor Necrosis Factor Receptor Superfamily Member 5 B Cell Surface Antigen CD40 or Bp50 or CDw40 or CD40L Receptor or TNFRSF5 or CD40 Pipeline Review H2 2018SummaryTumor Necrosis Factor Receptor...
View ArticleStem cell transplants to be used in treating Crohns disease The Conversation UK
The Conversation UKStem cell transplants to be used in treating Crohn's diseaseThe Conversation UKA new trial to assess the benefits and safety of stem cell transplantation for treatmentresistant...
View Article